Literature DB >> 17942516

Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.

Marcus Koch1, Jop Mostert, Alexander Arutjunyan, Michael Stepanov, Albert Teelken, Dorothea Heersema, Jacques De Keyser.   

Abstract

BACKGROUND: The reason for increased peripheral blood leukocyte (PBL) nitric oxide (NO) production in patients with multiple sclerosis (MS) is unknown.
OBJECTIVE: To investigate whether PBL NO production is related to measures of oxidative stress.
METHODS: PBL nitrite, diene conjugates (DC, a measure of undergone oxidative stress), antiradical activity (ARA) and antioxidant acitvity (AOA) were measured in 35 healthy control persons and 80 patients with MS. We investigated the correlation of these measures with a partial correlation analysis, with age as the control variable.
RESULTS: There was a significant correlation in both MS patients and healthy control persons between PBL nitrite levels and PBL DC, ARA and AOA. The correlations were stronger in healthy control persons. An analysis by disease subtype showed that the correlations were present in patients with relapsing-remitting and secondary progressive MS, but absent in primary progressive MS.
CONCLUSIONS: PBL nitrite levels and measures of oxidative stress are closely related in MS-patients as well as in healthy control persons. Increased serum NO levels in MS may be the result of a physiologic reaction to overall oxidative stress. The differences in the strength of correlation between different disease subtypes may reflect differences in leukocyte biology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942516     DOI: 10.1177/1352458507082075

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

1.  Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches.

Authors:  Natalia Niedziela; Monika Adamczyk-Sowa; Jacek T Niedziela; Bogdan Mazur; Ewa Kluczewska; Paweł Sowa; Mariusz Gąsior
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

Review 2.  Oxidative stress in multiple sclerosis: Central and peripheral mode of action.

Authors:  Kim Ohl; Klaus Tenbrock; Markus Kipp
Journal:  Exp Neurol       Date:  2015-11-26       Impact factor: 5.330

3.  Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.

Authors:  Marie Liebmann; Lisanne Korn; Claudia Janoschka; Stefanie Albrecht; Sarah Lauks; Alexander M Herrmann; Andreas Schulte-Mecklenbeck; Nicholas Schwab; Tilman Schneider-Hohendorf; Maria Eveslage; Brigitte Wildemann; Felix Luessi; Stephan Schmidt; Martin Diebold; Stefan Bittner; Catharina C Gross; Stjepana Kovac; Frauke Zipp; Tobias Derfuss; Tanja Kuhlmann; Simone König; Sven G Meuth; Heinz Wiendl; Luisa Klotz
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

4.  Redox processes in neurodegenerative disease involving reactive oxygen species.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

Review 5.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

Review 6.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

7.  Neuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brain.

Authors:  Omar M E Abdel-Salam; Yasser Ashry Khadrawy; Nadia A Mohammed
Journal:  EXCLI J       Date:  2012-03-29       Impact factor: 4.068

8.  Effects of Low-Frequency Electromagnetic Field on Oxidative Stress in Selected Structures of the Central Nervous System.

Authors:  Jan Budziosz; Agata Stanek; Aleksander Sieroń; Joanna Witkoś; Armand Cholewka; Karolina Sieroń
Journal:  Oxid Med Cell Longev       Date:  2018-12-13       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.